Cardiff Oncology
Priscilla Lewis CPA MBA has extensive experience in finance and accounting, with roles ranging from Financial Controller to Director of Finance and Operations. Priscilla has worked in various industries including life sciences, technology, and manufacturing, handling tasks such as financial reporting, compliance, equity tracking, tax support, and due diligence for investors. Their expertise includes SOX implementations, process improvements, system implementations, and budget/forecast preparation. Priscilla holds an MBA in Finance and a BBA in Accounting.
Cardiff Oncology
Cardiff Oncology is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Our goal is to overcome resistance, improve response to treatment and increase overall survival. We are developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.